NCT03127020 Phase 2 Study With PQR309 in Relapsed or Refractory Lymphoma Patients Status COMPLETED Phase PHASE2
NCT03126045 A Randomized Study Evaluating the Incidence of Post Lumbar Puncture Headache With Atraumatic Needles in Hematology Status COMPLETED Phase NA
NCT03126019 A Study of INCB050465 in Relapsed or Refractory Follicular Lymphoma Status COMPLETED Phase PHASE2
NCT03121625 CAR-T Therapy in Relapsed or Refractory Haematopoietic and Lymphoid Malignancies Status UNKNOWN Phase PHASE1
NCT03119467 Safety and Efficacy Study of RP4010, in Patients With Relapsed or Refractory Lymphomas Status TERMINATED Phase PHASE1
NCT03118180 CD19 Targeted Chimeric Antigen Receptor T Cells for B Cell Lymphoma Status UNKNOWN Phase PHASE1/PHASE2
NCT03098589 Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL) Status COMPLETED Phase N/A
NCT03086954 Study Evaluating the Efficacy and Safety With CAR-T Immunotherapy for CD19 Positive Lymphoma Status UNKNOWN Phase PHASE1
NCT03076437 Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies Status COMPLETED Phase PHASE1/PHASE2
NCT03070964 A Study of Plitidepsin in Patients With Relapsed or Refractory Angioimmunoblastic T-cell Lymphoma Status TERMINATED Phase PHASE2
NCT03062878 The Effects of Anthracycline-based Chemotherapy on Peripheral Vascular Function Status COMPLETED Phase N/A
NCT03061305 Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors Status TERMINATED Phase N/A
NCT03058289 A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 Status COMPLETED Phase PHASE1/PHASE2
NCT03057054 Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03054532 Phase II Study of Durvalumab in Combination With Lenalidomide in Relapsed/Refractory NK-T-cell Lymphoma Status UNKNOWN Phase PHASE2
NCT03052777 Using Telephone Counselling to Improve Exercise Participation in Hematologic Cancer Survivors Status COMPLETED Phase NA
NCT03039114 Study Evaluating Safety and Efficacy of INCB050465 Combined With Bendamustine and Obinutuzumab in Relapsed or Refractory Follicular Lymphoma (CITADEL-102) Status COMPLETED Phase PHASE1
NCT03030417 Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas Status COMPLETED Phase PHASE1
NCT03013491 PROCLAIM-CX-072: A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas Status TERMINATED Phase PHASE1/PHASE2